Photoallergy Potential of Dapsone Gel in Healthy Volunteers

This study will evaluate the potential of dapsone gel and its vehicle to cause a photoallergic reaction after repeated application and irradiation to the skin of healthy volunteers under controlled conditions.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Healthy Volunteers

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 1

Primary location

Fair Lawn, New Jersey, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

-Healthy adults.

Exclusion criteria

Skin diseases, excessive hair, tattoos, pigmentation, scars or moles that could interfere with patch application
Sensitivity to adhesive bandages or tape.

Treatment and study plan

dapsone gel

Drug

Patches containing dapsone gel will be applied to the skin.

dapsone gel vehicle

Drug

Patches containing dapsone gel vehicle will be applied to the skin.

Primary outcomes

Photoallergic (Sensitizing) Potential Using a Visual Scale

Time frame: Week 6

Sponsors and collaborators

Lead sponsor

Almirall, S.A.

Industry

Collaborators

Allergan

Registry information

Important dates

Study start: 2014
Primary completion: 2014
Study completion: 2014
First posted: Apr 21, 2014
Registry last updated: Oct 9, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed